Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy. I am a big fan of Optune, and think almost all GBM patients should be on it. It is the best treatment currently available, but it is not good enough by itself. We need to find what to add to it so that it works for everyone. This article presents one such combination. There are hundreds of other combinations that also need to be tested and the only way we are going to find the best combination is for us to track the outcomes of every patient who uses Optune. We are now tracking patients in our virtual trial project. Go to virtualtrials.com and click on virtual trial to learn about it and join. It is free - but you need to commit to posting update monthly for as long as needed. All brain tumor patients should be participating, but especially if you are considering Optune.
Help Us Better Understand Glioblastoma Multiforme - Paid survey! This is from our friends at Pinpoint Patient Recruiting. They are doing a survey about GBMs. They want GBM patients or caregivers to participate in an online survey, and are offering you $75 for your time. They will also make a donation to the Musella Foundation!
Please let us know if you do the survey and your experiences with it!
